Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| PTK2B | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 268.0 | Evidence |
|
||||
| PTK2B | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 268.0 | Evidence | |||||
| PTK2B | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence |
|
||||
| PTK2B | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 268.0 | Evidence |
|
||||
| PTK2B | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 268.0 | Evidence | |||||
| PTK2B | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 200.0 | Evidence | |||||
| PTK2B | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 200.0 | Evidence | |||||
| PTK2B | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 156.0 | Evidence |
|
||||
| PTK2B | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 139.0 | Evidence | |||||
| PTK2B | SYK | SYK: Tyrosine-protein kinase SYK | 139.0 | Evidence |
|
||||
| PTK2B | CRKL | CRKL: Crk-like protein | 139.0 | Evidence | |||||
| PTK2B | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
| PTK2B | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 121.0 | Evidence |
|
||||
| PTK2B | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| PTK2B | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 119.0 | Evidence | |||||
| PTK2B | LNK | SH2B3, LNK: SH2B adapter protein 3 | 119.0 | Evidence | |||||
| PTK2B | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 119.0 | Evidence | |||||
| PTK2B | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 119.0 | Evidence |
|
||||
| PTK2B | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 119.0 | Evidence | |||||
| PTK2B | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 119.0 | Evidence |
|
||||
| PTK2B | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 119.0 | Evidence | |||||
| PTK2B | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 119.0 | Evidence | |||||
| PTK2B | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 119.0 | Evidence | |||||
| PTK2B | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 117.0 | Evidence | |||||
| PTK2B | JAK1 | 106.0 | Evidence |
|
|||||
| PTK2B | LYN | LYN: Tyrosine-protein kinase Lyn | 106.0 | Evidence |
|
||||
| PTK2B | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 106.0 | Evidence |
|
||||
| PTK2B | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 106.0 | Evidence | |||||
| PTK2B | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 106.0 | Evidence | |||||
| PTK2B | VAV1 | VAV1, VAV: Proto-oncogene vav | 106.0 | Evidence |
|
||||
| PTK2B | CSK | CSK: Tyrosine-protein kinase CSK | 106.0 | Evidence | |||||
| PTK2B | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 106.0 | Evidence | |||||
| PTK2B | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| PTK2B | APS | SH2B2, APS: SH2B adapter protein 2 | 106.0 | Evidence | |||||
| PTK2B | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 106.0 | Evidence | |||||
| PTK2B | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 106.0 | Evidence | |||||
| PTK2B | HCK | N/A | 106.0 | Evidence | |||||
| PTK2B | STAT3 | 106.0 | Evidence |
|
|||||
| PTK2B | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 106.0 | Evidence |
|
||||
| PTK2B | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 104.0 | Evidence | |||||
| PTK2B | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 89.20 | Evidence | |||||
| PTK2B | GRB10 | N/A | 56.20 | Evidence | |||||
| PTK2B | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 32.90 | Evidence | |||||
| PTK2B | GRAP | GRAP: GRB2-related adapter protein | 32.90 | Evidence | |||||
| PTK2B | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 31.60 | Evidence | |||||
| PTK2B | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 22.30 | Evidence |
|
||||
| PTK2B | KIT | KIT: Mast/stem cell growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 22.30 | Evidence | |||||
| PTK2B | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 21.50 | Evidence | |||||
| PTK2B | SHB | SHB: SH2 domain-containing adapter protein B | 21.50 | Evidence | |||||
| PTK2B | STAM2 | STAM2: Signal transducing adapter molecule 2 | 20.50 | Evidence | |||||
| PTK2B | CTTN | CTTN, EMS1: Src substrate cortactin | 15.00 | Evidence | |||||
| PTK2B | IRS1 | IRS1: Insulin receptor substrate 1 | 15.00 | Evidence | |||||
| PTK2B | IRS2 | IRS2: Insulin receptor substrate 2 | 15.00 | Evidence | |||||
| PTK2B | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 14.10 | Evidence | |||||
| PTK2B | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 13.50 | Evidence |
|
||||
| PTK2B | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 13.50 | Evidence |
|
||||
| PTK2B | INSR | INSR: Insulin receptor precursor | 13.50 | Evidence | |||||
| PTK2B | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 13.50 | Evidence | |||||
| PTK2B | DOK1 | DOK1: Docking protein 1 | 13.40 | Evidence | |||||
| PTK2B | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||
| PTK2B | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||
| PTK2B | CD2AP | CD2AP: CD2-associated protein | 13.40 | Evidence | |||||
| PTK2B | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 13.40 | Evidence | |||||
| PTK2B | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 11.60 | Evidence | |||||
| PTK2B | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 11.60 | Evidence |
|
||||
| PTK2B | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 10.30 | Evidence | |||||
| PTK2B | ACTG1 | ACTB: Actin, cytoplasmic 1 | 10.30 | Evidence | |||||
| PTK2B | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
| PTK2B | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 9.92 | Evidence | |||||
| PTK2B | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 9.92 | Evidence | |||||
| PTK2B | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.92 | Evidence | |||||
| PTK2B | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
| PTK2B | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 9.92 | Evidence | |||||
| PTK2B | EPOR | EPOR: Erythropoietin receptor precursor | 9.92 | Evidence | |||||
| PTK2B | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 9.92 | Evidence | |||||
| PTK2B | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 9.92 | Evidence | |||||
| PTK2B | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 9.92 | Evidence | |||||
| PTK2B | ITGB4 | N/A | 9.92 | Evidence | |||||
| PTK2B | GHR | GHR: Growth hormone receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 9.92 | Evidence | |||||
| PTK2B | MET | MET: Hepatocyte growth factor receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 9.92 | Evidence | |||||
| PTK2B | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 9.92 | Evidence | |||||
| PTK2B | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
| PTK2B | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 8.89 | Evidence | |||||
| PTK2B | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 8.89 | Evidence | |||||
| PTK2B | SOS1 | SOS1: Son of sevenless homolog 1 | 8.89 | Evidence | |||||
| PTK2B | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 8.89 | Evidence | |||||
| PTK2B | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 8.89 | Evidence | |||||
| PTK2B | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 8.89 | Evidence | |||||
| PTK2B | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 8.89 | Evidence | |||||
| PTK2B | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 8.89 | Evidence | |||||
| PTK2B | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 8.55 | Evidence | |||||
| PTK2B | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 7.59 | Evidence | |||||
| PTK2B | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 6.80 | Evidence | |||||
| PTK2B | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 6.80 | Evidence | |||||
| PTK2B | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 6.80 | Evidence | |||||
| PTK2B | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence |
|
||||
| PTK2B | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 4.68 | Evidence | |||||
| PTK2B | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 4.68 | Evidence | |||||
| PTK2B | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 4.48 | Evidence | |||||
| PTK2B | LAT | LAT: Linker for activation of T-cells family member 1 | 4.48 | Evidence | |||||
| PTK2B | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 4.48 | Evidence | |||||
| PTK2B | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 4.48 | Evidence | |||||
| PTK2B | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 4.19 | Evidence | |||||
| PTK2B | RAN | RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran | 3.47 | Evidence | |||||
| PTK2B | EFNA1 | EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor | 3.02 | Evidence | |||||
| PTK2B | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 2.43 | Evidence | |||||
| PTK2B | CDC23 | CDC23: Cell division cycle protein 23 homolog | 2.28 | Evidence | |||||
| PTK2B | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 2.28 | Evidence |
|
||||
| PTK2B | CASP3 | CASP3, CPP32: Caspase-3 precursor | 2.28 | Evidence | |||||
| PTK2B | BCR | N/A | 2.28 | Evidence | |||||
| PTK2B | PTPN11 | N/A | 2.28 | Evidence |
|
||||
| PTK2B | HNRPK | N/A | 2.28 | Evidence | |||||
| PTK2B | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 1.91 | Evidence | |||||
| PTK2B | ACTB | ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 | 1.74 | Evidence | |||||
| PTK2B | EFNA5 | EFNA5, EPLG7, LERK7: Ephrin-A5 precursor | 1.27 | Evidence | |||||
| PTK2B | GNAI2 | Galphai2 protein | 1.16 | Evidence | |||||
| PTK2B | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 1.13 | Evidence | |||||
| PTK2B | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 1.13 | Evidence | |||||
| PTK2B | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
| PTK2B | BMX | N/A | 1.13 | Evidence | |||||
| PTK2B | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
| PTK2B | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 1.13 | Evidence | |||||
| PTK2B | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
| PTK2B | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 1.01 | Evidence | |||||
| PTK2B | NCK2 | NCK2: Cytoplasmic protein NCK2 | 1.01 | Evidence | |||||
| PTK2B | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 1.01 | Evidence | |||||
| PTK2B | RIN1 | RIN1: Ras and Rab interactor 1 | 1.01 | Evidence | |||||
| PTK2B | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 1.01 | Evidence | |||||
| PTK2B | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 1.01 | Evidence | |||||